Bydureon BCise (Exenatide ER): Uses, Side Effects, Status
Bydureon BCise (exenatide extended-release) is no longer sold in the US: it was discontinued on Oct. 28, 2024. Byetta has the same ingredient.
- Ingredient
- exenatide extended-release
- Status
- Discontinued Oct. 28, 2024
A quick view of half-life and weight loss
Measured in days, half-life is how long your body takes to clear half a dose. This information appears in section 12.3 of every FDA label.
Percentage of body weight Each medicine's results come from a different trial, with different doses and lengths. Compare each one with the placebo listed on its own page.
What people use instead of Bydureon BCise
If Bydureon BCise is what you took, ask your prescriber which of these options suits you.
| Medicine | Ingredient | How it is taken | List price |
|---|---|---|---|
 Ozempic | semaglutide | weekly injection | $1,027.51 per pen |
 Rybelsus | semaglutide | daily tablet | $1,027.51 per 30 tablets |
 Mounjaro | tirzepatide | weekly injection | $1,112.16 per fill |
 Trulicity | dulaglutide | weekly injection | $1,006.93 per fill |
 Victoza | liraglutide | daily injection | $543.51 per 2 pens |
| Byetta | exenatide | twice-daily injection | Not listed |
Source sites are pricinginfo.lilly.com 1 2, Novo Nordisk prices 1 2 3, plus TrumpRx.